Asia Pacific Blood Culture Tests 麻豆原创 2021-2031 by Product , Method , Technology , Application , End User , and Country: Trend Forecast and Growth Opportunity

Publication ID:

GRM0122036

Publication Date:

January 30, 2022

Pages:

110

Publisher:

Grace 麻豆原创 Data

Countries:

Asia Pacific [1]

USD 2,900.00

Diseases [2]

Diagnostics [3]

Country Overview (Pharma & Healthcare) [4]

Pharma & Healthcare [5]

Description:

Asia Pacific blood culture tests market will grow by 9.7% annually with a total addressable market cap of $16.74 billion over 2022-2031 owing to the rising prevalence of bloodstream infections, increasing number of sepsis cases and high cost of treatment, rising geriatric population, and the rising demand for rapid diagnostic techniques amid the COVID-19 pandemic.
Highlighted with 32 tables and 54 figures, this 110-page report 鈥淎sia Pacific Blood Culture Tests 麻豆原创 2021-2031 by Product (Consumables, Instruments, Software and Services), Method (Conventional, Automated), Technology (Culture-Based, Molecular, Proteomics, Others), Application (Bacteremia, Fungemia, Mycobacterial Detection), End User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories), and Country: Trend Forecast and Growth Opportunity鈥� is based on a comprehensive research of the entire Asia Pacific blood culture tests market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
鈥� 麻豆原创 Structure
鈥� Growth Drivers
鈥� Restraints and Challenges
鈥� Emerging Product Trends & 麻豆原创 Opportunities
鈥� Porter鈥檚 Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific blood culture tests market in every aspect of the classification from perspectives of Product, Method, Technology, Application, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Consumables
o Blood Culture Media
o Assay Kits & Reagents
o Blood Culture Accessories
鈥� Instruments
o Automated Blood Culture Systems
o Supporting Laboratory Equipment
鈥� Software and Services

Based on Method, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Conventional/Manual Methods
鈥� Automated Methods

Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Culture-Based Technologies
鈥� Molecular Technologies
o Microarrays
o Polymerase Chain Reaction (PCR)
o PNA-FISH
鈥� Proteomics Technology
鈥� Other Technologies

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Bacteremia
鈥� Fungemia
鈥� Mycobacterial Detection

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
鈥� Hospital Laboratories
鈥� Reference Laboratories
鈥� Academic Research Laboratories
鈥� Other End Users

Geographically, the following national/local markets are fully investigated:
鈥� Japan
鈥� China
鈥� South Korea
鈥� Australia
鈥� India
鈥� Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Autobio Diagnostics Co., Ltd.
Becton, Dickinson and Company (BD)
Binder Gmbh
Biobase Biotech (Jinan) Co., Ltd.
BioM茅rieux SA
Bruker Corporation
Carl Zeiss Ag
Cepheid Inc. (Danaher Corporation)
F. Hoffmann-La Roche Ltd.
Luminex Corporation
Neogen Corporation (Abtek Biologicals)
OpGen Inc.
T2 Biosystems, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents:

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of 麻豆原创 Research Methodology 11
1.2.2 麻豆原创 Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 麻豆原创 Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 麻豆原创 Overview and Dynamics 19
2.1 麻豆原创 Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the 麻豆原创 22
2.2 Major Growth Drivers 24
2.3 麻豆原创 Restraints and Challenges 29
2.4 Emerging Opportunities and 麻豆原创 Trends 32
2.5 Porter鈥檚 Fiver Forces Analysis 36
3 Segmentation of Asia Pacific 麻豆原创 by Product 40
3.1 麻豆原创 Overview by Product 40
3.2 Consumables 42
3.2.1 Blood Culture Media 44
3.2.2 Assay Kits & Reagents 45
3.2.3 Blood Culture Accessories 46
3.3 Instruments 47
3.3.1 Automated Blood Culture Systems 48
3.3.2 Supporting Laboratory Equipment 49
3.4 Software and Services 50
4 Segmentation of Asia Pacific 麻豆原创 by Method 51
4.1 麻豆原创 Overview by Method 51
4.2 Conventional/Manual Methods 53
4.3 Automated Methods 54
5 Segmentation of Asia Pacific 麻豆原创 by Technology 55
5.1 麻豆原创 Overview by Technology 55
5.2 Culture-Based Technologies 57
5.3 Molecular Technologies 58
5.3.1 Microarrays 59
5.3.2 Polymerase Chain Reaction (PCR) 60
5.3.3 PNA-FISH 61
5.4 Proteomics Technology 62
5.5 Other Technologies 63
6 Segmentation of Asia Pacific 麻豆原创 by Application 64
6.1 麻豆原创 Overview by Application 64
6.2 Bacteremia 66
6.3 Fungemia 67
6.4 Mycobacterial Detection 68
7 Segmentation of Asia Pacific 麻豆原创 by End User 69
7.1 麻豆原创 Overview by End User 69
7.2 Hospital Laboratories 71
7.3 Reference Laboratories 72
7.4 Academic Research Laboratories 73
7.5 Other End Users 74
8 Asia-Pacific 麻豆原创 2021-2031 by Country 75
8.1 Overview of Asia-Pacific 麻豆原创 75
8.2 Japan 78
8.3 China 81
8.4 Australia 83
8.5 India 85
8.6 South Korea 87
8.7 Rest of APAC Region 89
9 Competitive Landscape 91
9.1 Overview of Key Vendors 91
9.2 New Product Launch, Partnership, Investment, and M&A 94
9.3 Company Profiles 95
Autobio Diagnostics Co., Ltd. 95
Becton, Dickinson and Company (BD) 97
Binder Gmbh 98
Biobase Biotech (Jinan) Co., Ltd. 99
BioM茅rieux SA 100
Bruker Corporation 101
Carl Zeiss Ag 102
Cepheid Inc. (Danaher Corporation) 103
F. Hoffmann-La Roche Ltd. 104
Luminex Corporation 105
Neogen Corporation (Abtek Biologicals) 106
OpGen Inc. 107
T2 Biosystems, Inc. 108
Thermo Fisher Scientific Inc. 109
RELATED REPORTS 110

Companies Mentioned:

Selected Key Players:
Autobio Diagnostics Co., Ltd.
Becton, Dickinson and Company (BD)
Binder Gmbh
Biobase Biotech (Jinan) Co., Ltd.
BioM茅rieux SA
Bruker Corporation
Carl Zeiss Ag
Cepheid Inc. (Danaher Corporation)
F. Hoffmann-La Roche Ltd.
Luminex Corporation
Neogen Corporation (Abtek Biologicals)
OpGen Inc.
T2 Biosystems, Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.